Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion type Assertion NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_head.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion description "[The cases studied comprised reactive lymphoid hyperplasia (RLH; n = 19), follicular lymphoma (FL; n = 50), low-grade mucosa-associated lymphoid tissue (MALT) lymphoma (n = 24), mantle cell lymphoma (n = 19), splenic marginal zone lymphoma (n = 13), diffuse large B-cell lymphoma (DLBCL; n = 54), Burkitt's lymphoma (BL; n = 20), nodular lymphocyte predominance Hodgkin's disease (NLPHD; n = 16), and classic Hodgkin's disease (CHD; n = 13).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_provenance.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion evidence source_evidence_literature NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_provenance.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion SIO_000772 10843287 NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_provenance.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion wasDerivedFrom befree-20140225 NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_provenance.
- NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_assertion wasGeneratedBy ECO_0000203 NP697233.RA4MiIvtSdYGWaQcfbpGPTBK-dXQFZOlU_HCh1A1mvp9U130_provenance.